Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Rating) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 1,350,000 shares, a decrease of 19.2% from the March 31st total of 1,670,000 shares. Approximately 2.8% of the company’s shares are sold short. Based on an average daily trading volume, of 616,100 shares, the short-interest ratio is presently 2.2 days.
Institutional investors have recently added to or reduced their stakes in the company. Citigroup Inc. increased its position in shares of Aveanna Healthcare by 147.8% in the third quarter. Citigroup Inc. now owns 4,550 shares of the company’s stock worth $36,000 after acquiring an additional 2,714 shares in the last quarter. Regentatlantic Capital LLC acquired a new stake in Aveanna Healthcare during the 1st quarter valued at $34,000. Dynamic Technology Lab Private Ltd acquired a new stake in Aveanna Healthcare during the 3rd quarter valued at $95,000. Arizona State Retirement System acquired a new stake in Aveanna Healthcare during the 4th quarter valued at $92,000. Finally, Metropolitan Life Insurance Co NY grew its holdings in Aveanna Healthcare by 73.2% during the 4th quarter. Metropolitan Life Insurance Co NY now owns 13,327 shares of the company’s stock valued at $99,000 after purchasing an additional 5,632 shares in the last quarter. 95.00% of the stock is owned by institutional investors.
AVAH has been the topic of several recent analyst reports. Zacks Investment Research raised shares of Aveanna Healthcare from a “sell” rating to a “hold” rating in a research note on Tuesday, April 19th. Stephens reduced their price objective on shares of Aveanna Healthcare from $11.50 to $7.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 30th. Truist Financial reduced their price objective on shares of Aveanna Healthcare from $10.00 to $5.00 and set a “buy” rating on the stock in a research note on Wednesday, March 30th. Barclays cut their price target on shares of Aveanna Healthcare from $16.00 to $7.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 30th. Finally, Royal Bank of Canada cut their price target on shares of Aveanna Healthcare from $16.00 to $9.00 and set an “outperform” rating on the stock in a research note on Thursday, March 31st. Three analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Aveanna Healthcare presently has an average rating of “Buy” and a consensus price target of $8.90.
Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last released its quarterly earnings data on Monday, March 28th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by ($0.01). Aveanna Healthcare had a positive return on equity of 11.03% and a negative net margin of 6.97%. The business had revenue of $414.07 million during the quarter, compared to analyst estimates of $420.19 million. On average, research analysts expect that Aveanna Healthcare will post 0.4 EPS for the current fiscal year.
Aveanna Healthcare Company Profile (Get Rating)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
- Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
- onsemi Is A Deep-Value In The Chip Sector
- Is The FOMC About To Spark A Massive Stock Market Correction?
- Enphase Energy Has a Sunny Future With Some Clouds in the Short Term
- Knight-Swift Transportation Stock is a Logistics Winner
- Why is Chevron Stock Falling After Strong Earnings?
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.